GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 46 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,768,456 | -30.3% | 2,942,807 | -2.4% | 0.15% | -32.7% |
Q3 2022 | $9,713,000 | -41.0% | 3,016,371 | +0.8% | 0.22% | -4.8% |
Q2 2022 | $16,465,000 | +202.6% | 2,993,695 | +28.2% | 0.23% | +273.8% |
Q1 2022 | $5,442,000 | -48.5% | 2,335,476 | +33.4% | 0.06% | -37.8% |
Q4 2021 | $10,574,000 | -34.3% | 1,750,707 | +50.8% | 0.10% | -36.8% |
Q3 2021 | $16,102,000 | +24.2% | 1,160,891 | +16.4% | 0.16% | +33.6% |
Q2 2021 | $12,964,000 | -4.6% | 997,238 | +13.0% | 0.12% | -7.9% |
Q1 2021 | $13,595,000 | – | 882,768 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 2,890,102 | $9,306,000 | 0.72% |
Orbimed Advisors | 7,884,870 | $25,389,000 | 0.47% |
GREAT POINT PARTNERS LLC | 449,049 | $1,446,000 | 0.35% |
Vivo Capital, LLC | 961,359 | $3,096,000 | 0.34% |
Capital International, Inc./CA/ | 3,016,371 | $9,713,000 | 0.22% |
Temasek Holdings (Private) Ltd | 9,901,940 | $31,884,247 | 0.19% |
EcoR1 Capital, LLC | 1,921,310 | $6,187,000 | 0.18% |
Capital International Sarl | 304,582 | $981,000 | 0.08% |
FEDERATED HERMES, INC. | 1,298,578 | $4,181,000 | 0.01% |
Cannell Capital | 14,299 | $46,000 | 0.01% |